Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI

BackgroundSeveral MR-based attenuation correction (AC) approaches were developed to conquer the challenging AC in hybrid PET/MR imaging. These AC methods are commonly evaluated on standardized uptake values or tissue concentration. However, in neurotransmitter system studies absolute quantification...

Full description

Bibliographic Details
Main Authors: Lucas Rischka, Gregor Gryglewski, Neydher Berroterán-Infante, Ivo Rausch, Gregory Miles James, Manfred Klöbl, Helen Sigurdardottir, Markus Hartenbach, Andreas Hahn, Wolfgang Wadsak, Markus Mitterhauser, Thomas Beyer, Siegfried Kasper, Daniela Prayer, Marcus Hacker, Rupert Lanzenberger
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2019.01422/full
id doaj-7e5d790830304197bdc088e565bce28f
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Lucas Rischka
Gregor Gryglewski
Neydher Berroterán-Infante
Ivo Rausch
Gregory Miles James
Manfred Klöbl
Helen Sigurdardottir
Markus Hartenbach
Andreas Hahn
Wolfgang Wadsak
Wolfgang Wadsak
Markus Mitterhauser
Markus Mitterhauser
Thomas Beyer
Siegfried Kasper
Daniela Prayer
Marcus Hacker
Rupert Lanzenberger
spellingShingle Lucas Rischka
Gregor Gryglewski
Neydher Berroterán-Infante
Ivo Rausch
Gregory Miles James
Manfred Klöbl
Helen Sigurdardottir
Markus Hartenbach
Andreas Hahn
Wolfgang Wadsak
Wolfgang Wadsak
Markus Mitterhauser
Markus Mitterhauser
Thomas Beyer
Siegfried Kasper
Daniela Prayer
Marcus Hacker
Rupert Lanzenberger
Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
Frontiers in Physiology
attenuation correction
PET/MRI
serotonin transporter
[11C]DASB
occupancy
absolute quantification
author_facet Lucas Rischka
Gregor Gryglewski
Neydher Berroterán-Infante
Ivo Rausch
Gregory Miles James
Manfred Klöbl
Helen Sigurdardottir
Markus Hartenbach
Andreas Hahn
Wolfgang Wadsak
Wolfgang Wadsak
Markus Mitterhauser
Markus Mitterhauser
Thomas Beyer
Siegfried Kasper
Daniela Prayer
Marcus Hacker
Rupert Lanzenberger
author_sort Lucas Rischka
title Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
title_short Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
title_full Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
title_fullStr Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
title_full_unstemmed Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
title_sort attenuation correction approaches for serotonin transporter quantification with pet/mri
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2019-11-01
description BackgroundSeveral MR-based attenuation correction (AC) approaches were developed to conquer the challenging AC in hybrid PET/MR imaging. These AC methods are commonly evaluated on standardized uptake values or tissue concentration. However, in neurotransmitter system studies absolute quantification is more favorable due to its accuracy. Therefore, our aim was to investigate the accuracy of segmentation- and atlas-based MR AC approaches on serotonin transporter (SERT) distribution volumes and occupancy after a drug challenge.Methods18 healthy subjects (7 male) underwent two [11C]DASB PET/MRI measurements in a double-blinded, placebo controlled, cross-over design. After 70 min the selective serotonin reuptake inhibitor (SSRI) citalopram or a placebo was infused. The parameters total and specific volume of distribution (VT, VS = BPP) and occupancy were quantified. All subjects underwent a low-dose CT scan as reference AC method. Besides the standard AC approaches DIXON and UTE, a T1-weighted structural image was recorded to estimate a pseudo-CT based on an MR/CT database (pseudoCT). Another evaluated AC approach superimposed a bone model on AC DIXON. Lastly, an approach optimizing the segmentation of UTE images was analyzed (RESOLUTE). PET emission data were reconstructed with all 6 AC methods. The accuracy of the AC approaches was evaluated on a region of interest-basis for the parameters VT, BPP, and occupancy with respect to the results of AC CT.ResultsVariations for VT and BPP were found with all AC methods with bias ranging from −15 to 17%. The smallest relative errors for all regions were found with AC pseudoCT (<|5%|). Although the bias between BPP SSRI and BPP placebo varied markedly with AC DIXON (<|12%|) and AC UTE (<|9%|), a high correlation to AC CT was obtained (r2∼1). The relative difference of the occupancy for all tested AC methods was small for SERT high binding regions (<|4%|).ConclusionThe high correlation might offer a rescaling from the biased parameters VT and BPP to the true values. Overall, the pseudoCT approach yielded smallest errors and the best agreement with AC CT. For SERT occupancy, all AC methods showed little bias in high binding regions, indicating that errors may cancel out in longitudinal assessments.
topic attenuation correction
PET/MRI
serotonin transporter
[11C]DASB
occupancy
absolute quantification
url https://www.frontiersin.org/article/10.3389/fphys.2019.01422/full
work_keys_str_mv AT lucasrischka attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT gregorgryglewski attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT neydherberroteraninfante attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT ivorausch attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT gregorymilesjames attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT manfredklobl attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT helensigurdardottir attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT markushartenbach attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT andreashahn attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT wolfgangwadsak attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT wolfgangwadsak attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT markusmitterhauser attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT markusmitterhauser attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT thomasbeyer attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT siegfriedkasper attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT danielaprayer attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT marcushacker attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
AT rupertlanzenberger attenuationcorrectionapproachesforserotonintransporterquantificationwithpetmri
_version_ 1725165528422547456
spelling doaj-7e5d790830304197bdc088e565bce28f2020-11-25T01:12:34ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2019-11-011010.3389/fphys.2019.01422469884Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRILucas Rischka0Gregor Gryglewski1Neydher Berroterán-Infante2Ivo Rausch3Gregory Miles James4Manfred Klöbl5Helen Sigurdardottir6Markus Hartenbach7Andreas Hahn8Wolfgang Wadsak9Wolfgang Wadsak10Markus Mitterhauser11Markus Mitterhauser12Thomas Beyer13Siegfried Kasper14Daniela Prayer15Marcus Hacker16Rupert Lanzenberger17Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, AustriaQIMP Group, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, AustriaCBmed, Graz, AustriaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, AustriaLudwig Boltzmann Institute Applied Diagnostics, Vienna, AustriaQIMP Group, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaDivision of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, AustriaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, AustriaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaBackgroundSeveral MR-based attenuation correction (AC) approaches were developed to conquer the challenging AC in hybrid PET/MR imaging. These AC methods are commonly evaluated on standardized uptake values or tissue concentration. However, in neurotransmitter system studies absolute quantification is more favorable due to its accuracy. Therefore, our aim was to investigate the accuracy of segmentation- and atlas-based MR AC approaches on serotonin transporter (SERT) distribution volumes and occupancy after a drug challenge.Methods18 healthy subjects (7 male) underwent two [11C]DASB PET/MRI measurements in a double-blinded, placebo controlled, cross-over design. After 70 min the selective serotonin reuptake inhibitor (SSRI) citalopram or a placebo was infused. The parameters total and specific volume of distribution (VT, VS = BPP) and occupancy were quantified. All subjects underwent a low-dose CT scan as reference AC method. Besides the standard AC approaches DIXON and UTE, a T1-weighted structural image was recorded to estimate a pseudo-CT based on an MR/CT database (pseudoCT). Another evaluated AC approach superimposed a bone model on AC DIXON. Lastly, an approach optimizing the segmentation of UTE images was analyzed (RESOLUTE). PET emission data were reconstructed with all 6 AC methods. The accuracy of the AC approaches was evaluated on a region of interest-basis for the parameters VT, BPP, and occupancy with respect to the results of AC CT.ResultsVariations for VT and BPP were found with all AC methods with bias ranging from −15 to 17%. The smallest relative errors for all regions were found with AC pseudoCT (<|5%|). Although the bias between BPP SSRI and BPP placebo varied markedly with AC DIXON (<|12%|) and AC UTE (<|9%|), a high correlation to AC CT was obtained (r2∼1). The relative difference of the occupancy for all tested AC methods was small for SERT high binding regions (<|4%|).ConclusionThe high correlation might offer a rescaling from the biased parameters VT and BPP to the true values. Overall, the pseudoCT approach yielded smallest errors and the best agreement with AC CT. For SERT occupancy, all AC methods showed little bias in high binding regions, indicating that errors may cancel out in longitudinal assessments.https://www.frontiersin.org/article/10.3389/fphys.2019.01422/fullattenuation correctionPET/MRIserotonin transporter[11C]DASBoccupancyabsolute quantification